Artia Global Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84M | Sell |
20,970
-7,630
| -27% | -$2.49M | 1.65% | 11 |
|
|
2025
Q1 | $7.72M | Sell |
28,600
-27,800
| -49% | -$7.51M | 1.95% | 12 |
|
|
2024
Q4 | $13.3M | Buy |
56,400
+21,400
| +61% | +$5.04M | 4.74% | 8 |
|
|
2024
Q3 | $9.63M | Hold |
35,000
| – | – | 2.62% | 7 |
|
|
2024
Q2 | $8.51M | Buy |
+35,000
| New | +$8.51M | 1.64% | 8 |
|
|
2023
Q4 | – | Sell |
-15,971
| Closed | -$2.83M | – | 28 |
|
|
2023
Q3 | $2.83M | Hold |
15,971
| – | – | 1.18% | 16 |
|
|
2023
Q2 | $3.03M | Hold |
15,971
| – | – | 1.05% | 23 |
|
|
2023
Q1 | $3.2M | Hold |
15,971
| – | – | 1.18% | 16 |
|
|
2022
Q4 | $3.8M | Buy |
+15,971
| New | +$3.8M | 1.45% | 14 |
|